T cells infiltrate the liver and kill hepatocytes in HLA-B *57:01-associated floxacillin-induced liver injury

American Journal of Pathology

Volumn 184, Issue 6, 2014, Pages 1677-1682

  Wuillemin, Natascha ^a,b   Terracciano, Luigi ^c   Beltraminelli, Helmut ^a   Schlapbach, Christoph ^a   Fontana, Stefano ^e   Krähenbühl, Stephan ^d   Pichler, Werner J ^a   Yerly, Daniel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e SRK   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; HLA B57 ANTIGEN; ANTIINFECTIVE AGENT; HLA B ANTIGEN; HLA-B*57:01 ANTIGEN;

ADAPTIVE IMMUNITY; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CONCENTRATION RESPONSE; CYTOTOXIC T LYMPHOCYTE; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER BIOPSY; LIVER CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; TARGET CELL; TOXIC HEPATITIS; CELL LINE; CLINICAL TRIAL; FEMALE; GENETICS; IMMUNOLOGY; LIVER; MALE; PATHOLOGY;

ANTI-BACTERIAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DRUG-INDUCED LIVER INJURY; FEMALE; FLOXACILLIN; HEPATOCYTES; HLA-B ANTIGENS; HUMANS; LIVER; MALE;

EID: 84901005722     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.02.018     Document Type: Article

References (36)

1. W.M. Lee Drug-induced hepatotoxicity N Engl J Med 349 2003 474 485
2. M.P. Holt, and C. Ju Mechanisms of drug-induced liver injury AAPS J 8 2006 E48 E54
3. M.L. Hautekeete, Y. Horsmans, C. Van Waeyenberge, C. Demanet, J. Henrion, L. Verbist, R. Brenard, C. Sempoux, P.P. Michielsen, P.S. Yap, J. Rahier, and A.P. Geubel HLA association of amoxicillin-clavulanate-induced hepatitis Gastroenterology 117 1999 1181 1186
4. M.I. Lucena, M. Molokhia, Y. Shen, T.J. Urban, G.P. Aithal, R.J. Andrade, C.P. Day, F. Ruiz-Cabello, P.T. Donaldson, C. Stephens, M. Pirmohamed, M. Romero-Gomez, J.M. Navarro, R.J. Fontana, M. Miller, M. Groome, E. Bondon-Guitton, A. Conforti, B.H. Stricker, A. Carvajal, L. Ibanez, Q.Y. Yue, M. Eichelbaum, A. Floratos, I. Pe'er, M.J. Daly, D.B. Goldstein, J.F. Dillon, M.R. Nelson, P.B. Watkins, A.K. Daly Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles Gastroenterology 141 2011 338 347
5. J. O'Donohue, K.A. Oien, P. Donaldson, J. Underhill, M. Clare, R.N. MacSween, and P.R. Mills Co-amoxiclav jaundice: clinical and histological features and HLA class II association Gut 47 2000 717 720
6. *5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
7. N. Wuillemin, J. Adam, S. Fontana, S. Krähenbühl, W.J. Pichler, and D. Yerly HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin J Immunol 190 2013 4956 4964
8. *57:01- restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury Hepatology 57 2013 727 739
9. B. Schnyder, K. Frutig, D. Mauri-Hellweg, A. Limat, N. Yawalkar, and W.J. Pichler T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction Clin Exp Allergy 28 1998 1412 1417
10. M. Hertl, H. Bohlen, F. Jugert, C. Boecker, R. Knaup, and H.F. Merk Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics J Invest Dermatol 101 1993 794 799
11. N. Yawalkar, F. Egli, Y. Hari, H. Nievergelt, L.R. Braathen, and W.J. Pichler Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions Clin Exp Allergy 30 2000 847 855
12. W.H. Chung, S.I. Hung, J.Y. Yang, S.C. Su, S.P. Huang, C.Y. Wei, S.W. Chin, C.C. Chiou, S.C. Chu, H.C. Ho, C.H. Yang, C.F. Lu, J.Y. Wu, Y.D. Liao, and Y.T. Chen Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
13. M.F. Amante, A.V. Filippini, N. Cejas, J. Lendoire, O. Imventarza, and C. Parisi Dress syndrome and fulminant hepatic failure induced by lamotrigine Ann Hepatol 8 2009 75 77
14. W.K. Syn, D.J. Naisbitt, A.P. Holt, M. Pirmohamed, and D.J. Mutimer Carbamazepine-induced acute liver failure as part of the DRESS syndrome [erratum in: Int J Clin Pract 2005, 59:1371] Int J Clin Pract 59 2005 988 991
15. M. Mennicke, A. Zawodniak, M. Keller, L. Wilkens, N. Yawalkar, F. Stickel, A. Keogh, D. Inderbitzin, D. Candinas, and W.J. Pichler Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation Am J Transplant 9 2009 2197 2202
16. B. Eksteen, A.J. Grant, A. Miles, S.M. Curbishley, P.F. Lalor, S.G. Hübscher, M. Briskin, M. Salmon, and D.H. Adams Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 2004 1511 1517
17. K. Miura, L. Yang, N. van Rooijen, H. Ohnishi, and E. Seki Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Am J Physiol Gastrointest Liver Physiol 302 2012 G1310 G1321
18. S.S. Metkar, B. Wang, M.L. Ebbs, J.H. Kim, Y.J. Lee, S.M. Raja, and C.J. Froelich Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis J Cell Biol 160 2003 875 885
19. M.J. Pinkoski, N.J. Waterhouse, J.A. Heibein, B.B. Wolf, T. Kuwana, J.C. Goldstein, D.D. Newmeyer, R.C. Bleackley, and D.R. Green Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway J Biol Chem 276 2001 12060 12067
20. P. Forch, O. Puig, N. Kedersha, C. Martinez, S. Granneman, B. Séraphin, P. Anderson, and J. Valcárcel The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing Mol Cell 6 2000 1089 1098
21. J.M. Izquierdo, and J. Valcárcel Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing J Biol Chem 282 2007 1539 1543
22. Q. Tian, M. Streuli, H. Saito, S.F. Schlossman, and P. Anderson A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells Cell 67 1991 629 639
23. C. Schlapbach, A. Zawodniak, N. Irla, J. Adam, R.E. Hunger, D. Yerly, W.J. Pichler, and N. Yawalkar NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions Allergy 66 2011 1469 1476
24. T. Kataoka, N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity J Immunol 156 1996 3678 3686
25. P.C. Kuechler, M. Britschgi, S. Schmid, Y. Hari, B. Grabscheid, and W.J. Pichler Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies Allergy 59 2004 613 622
26. C. Gremion, B. Grabscheid, B. Wölk, D. Moradpour, J. Reichen, W. Pichler, and A. Cerny Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction J Virol 78 2004 2152 2157
27. J. Adam, K.K. Eriksson, B. Schnyder, S. Fontana, W.J. Pichler, and D. Yerly Avidity determines T-cell reactivity in abacavir hypersensitivity Eur J Immunol 42 2012 1706 1716
28. D. Kägi, F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity Science 265 1994 528 530
29. M.J. Pinkoski, T. Brunner, D.R. Green, and T. Lin Fas and Fas ligand in gut and liver Am J Physiol Gastrointest Liver Physiol 278 2000 G354 G366
30. P.R. Galle, W.J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P.H. Krammer, and L. Runkel Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage J Exp Med 182 1995 1223 1230
31. J. Yun, J. Mattsson, K. Schnyder, S. Fontana, C. Largiadèr, W. Pichler, and D. Yerly Allopurinol hypersensitivity is primarily mediated by dose dependent oxypurinol-specific T cell response Clin Exp Allergy 43 2013 1246 1255
32. C.B. Landersdorfer, C.M. Kirkpatrick, M. Kinzig-Schippers, J.B. Bulitta, U. Holzgrabe, G.L. Drusano, and F. Sörgel Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin Antimicrob Agents Chemother 51 2007 3290 3297
33. M.M. Alvarez Ferrero, T.B. Vree, A.M. Baars, and T.J. Slooff Plasma and bone concentrations of cefuroxime and flucloxacillin. Oral versus parenteral administration in 20 arthroplasties Acta Orthop Scand 64 1993 525 529
34. C.K. Fairley, J.J. McNeil, P. Desmond, R. Smallwood, H. Young, A. Forbes, P. Purcell, and I. Boyd Risk factors for development of flucloxacillin associated jaundice [erratum in: BMJ 1993, 307:1179] BMJ 306 1993 233 235
35. R. Olsson, B.E. Wiholm, C. Sand, L. Zettergren, R. Hultcrantz, and M. Myrhed Liver damage from flucloxacillin, cloxacillin and dicloxacillin J Hepatol 15 1992 154 161
36. Z. Spanou, M. Keller, M. Britschgi, N. Yawalkar, T. Fehr, J. Neuweiler, M. Gugger, M. Mohaupt, and W.J. Pichler Involvement of drug-specific T cells in acute drug-induced interstitial nephritis J Am Soc Nephrol 17 2006 2919 2927